The weekly litigation news digest is live. Subscribe now

IP Verse

Yeda Research competitive analysis

Loading summary...

Latest patents of Yeda Research opposed by its competitors

Explore Yeda Research's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Dec 4, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3793447
Jan 18, 2023System And Method For Orientating Capture Of Ultrasound Images1
EP2566954
Nov 2, 2022Immunotherapy Using Redirected Allogeneic Cells1
EP3097923
Jul 27, 2022Redirected, Genetically-Engineered T Regulatory Cells And Their Use In Suppression Of Autoimmune And Inflammatory Disease1
EP3409286
Aug 12, 2020Low Frequency Glatiramer Acetate Therapy2
EP3199172
Jul 11, 2018Dosing Regimen For Multiple Sclerosis5
EP2630962
Jun 27, 2018Low Frequency Glatiramer Acetate Therapy5
EP2949335
Jan 4, 2017Low Frequency Glatiramer Acetate Therapy6

Latest PTAB cases involving Yeda Research

Discover the latest PTAB cases involving Yeda Research, highlighting their recent legal challenges and patent disputes.

Last updated on: Dec 5, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Yeda Research

IPR2017-00195Nov 2, 2016MYLAN PHARMACEUTICALSYEDA RESEARCHTerminated
PGR2016-00028Jul 12, 2016AMNEAL PHARMACEUTICALSYEDA RESEARCHTerminated
PGR2016-00010Feb 16, 2016MYLAN PHARMACEUTICALSYEDA RESEARCHInstitution Denied
IPR2015-01976Sep 25, 2015AMNEAL PHARMACEUTICALSYEDA RESEARCHFinal Written Decision
IPR2015-01980Sep 25, 2015AMNEAL PHARMACEUTICALSYEDA RESEARCHFinal Written Decision
IPR2015-01981Sep 25, 2015AMNEAL PHARMACEUTICALSYEDA RESEARCHFinal Written Decision
IPR2015-00830Mar 3, 2015MYLAN PHARMACEUTICALSYEDA RESEARCHFinal Written Decision
IPR2015-00644Feb 7, 2015MYLAN PHARMACEUTICALSYEDA RESEARCHFinal Written Decision
IPR2015-00643Feb 6, 2015MYLAN PHARMACEUTICALSYEDA RESEARCHFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Yeda Research with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Dec 4, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
YEDA RESEARCH - 21 - 9
AMNEAL PHARMACEUTICALS - - 31 -
MYLAN PHARMACEUTICALS - - 94 -
SYNTHON3316 - -